Biochemistry, Genetics and Molecular Biology
ErbB
100%
Protein Biosynthesis
100%
Epidermal Growth Factor Receptor
93%
Carcinogenesis
90%
Energy Metabolism
80%
Hormone Sensitivity
80%
Major Facilitator Superfamily
80%
Integrin
80%
Translation Initiation
80%
Synapsin I
80%
Epigenetics
80%
Cancer Cell Culture
80%
Oncogene
80%
SARS Coronavirus
80%
Fluorescence in Situ Hybridization
40%
Immunological Tolerance
40%
Intrinsic Factor
40%
Initiation Factor
26%
Overall Survival
26%
Survival Rate
26%
Drug Efficacy
26%
Kinase
20%
Phosphotransferase
20%
Cell Communication
20%
Eukaryotic Translation
20%
Genotyping
13%
Drug Targeting
13%
Awareness
13%
Somatic Mutation
13%
Cancer Cell
13%
Drug Response
13%
Signal Transduction
13%
Bisulfite
11%
DNA Methyltransferase
11%
Focal Adhesion
10%
Cell Migration
10%
Surface Property
10%
Mouse Model
10%
down Regulation
10%
Medicine and Dentistry
Malignant Neoplasm
93%
Breast Cancer
80%
Mechanistic Target of Rapamycin
80%
Quantitative Reverse Transcription Polymerase Chain Reaction
80%
Next Generation Sequencing
80%
Bladder Cancer
80%
Mammalian Target of Rapamycin
80%
Carcinogenesis
80%
Neoplasm
76%
Diagnosis
53%
Immunohistochemistry
40%
Fluorescence in Situ Hybridization
40%
Energy Metabolism
26%
Hormone Sensitivity
26%
Thyroid Cancer
26%
Autoimmune Hepatitis
26%
Epigenetic Modification
20%
Molecular Diagnostics
20%
Environmental Influence
20%
DNA Methylation
20%
Initiation Factor
13%
Biological Marker
13%
Cancer Cell
13%
Personalized Medicine
13%
Polymerase Chain Reaction
13%
Metastasis Potential
13%
Recurrence Risk
13%
Tumor Recurrence
13%
Health Care Cost
13%
Ribosome
13%
Epidermal Growth Factor Receptor
13%
Somatic Mutation
13%
Awareness
13%
Glioblastoma
13%
Mammalian Target of Rapamycin Inhibitor
13%
Colorectal Cancer
13%
False Negative Result
13%
Biogenesis
13%
Cell Cycle Progression
13%
Translation (Protein Synthesis)
13%
Ductal Carcinoma
13%
Gene Expression Profiling
11%
Research Design
11%
Squamous Cell Carcinoma
11%
Bladder Carcinogenesis
11%
Papilloma
11%
Papillary Carcinoma
11%
Pharmacology, Toxicology and Pharmaceutical Science
Oncogene Addiction
80%
Liver Carcinogenesis
80%
Mammalian Target of Rapamycin
80%
Carcinogenesis
80%
Bladder Cancer
80%
Neoplasm
80%
Initiation Factor
53%
Thyroid Cancer
40%
Malignant Neoplasm
40%
Nonalcoholic Fatty Liver
26%
Alcohol Liver Disease
26%
Liver Cirrhosis
26%
Hepatitis
26%
Acute Liver Failure
26%
Intrinsic Factor
26%
Pathophysiology
20%
Cytotoxic Agent
20%
Phosphotransferase
20%
Oncoprotein
20%
Histone
20%
Glioblastoma
13%
Lethality
13%
Mammalian Target of Rapamycin Inhibitor
13%
Bladder Carcinogenesis
11%
Papillary Carcinoma
11%
Papilloma
11%
